Cash, cash equivalents, and short-term investments totaled $416 million; days sales outstanding was 30 days; inventory days improved to 86 days from 94 days.
GAAP gross margin was 56.1%, non-GAAP gross margin was 56.3%, up 90 basis points sequentially and above guidance midpoint.
GAAP loss per share was $0.67; non-GAAP earnings per share was $0.11, beating guidance midpoint by $0.02.
GAAP operating loss was $23 million; non-GAAP operating income was $1 million.
Home & Life segment revenue was $83 million, up 2% sequentially and 45% year-over-year, led by medical customer ramps and smart home stabilization.
Industrial and Commercial segment revenue was $110 million, up 14% sequentially and 25% year-over-year, driven by electronic shelf labeling, smart meter rollouts, and broad industrial demand.
Silicon Labs reported Q2 revenue of $193 million, up 9% sequentially and 33% year-over-year, in line with guidance midpoint.
Capital expenditures were $0.2 million, in line with expectations.
Convertible notes outstanding are approximately $33 million, convertible at $1.60 per share, with the first payment due September 1, 2025.
MicroVision reported Q2 2025 revenues of $0.15 million, primarily driven by sales in the industrial verticals.
Raised approximately $35 million net from ATM during Q2, extending runway into 2027.
R&D and SG&A expenses for Q2 2025 were $14.1 million, including $3.4 million of noncash charges; cash expenses were $11 million, representing a 44% year-over-year reduction.
The company ended Q2 2025 with $91.4 million in cash and cash equivalents, plus $76.5 million available under the ATM facility and $30 million undrawn under the convertible note facility.
Dafinchi